BioSpace News Archive

Pharmacy Compounding Accreditation Board (PCAB) Recognizes EnvisionPharmacies for Operational and Clinical Excellence in the Creation of Customized Medications Patients Needing Alternative Medications Can Trust EnvisionPharmacies for Quality Compounded Prescriptions

PixarBio Corporation clarifies their early 2016 decision to terminate the US FDA Orphan Drug Designation application process for treating Trigeminal Neuralgia.

Theravance Biopharma, Inc. reported financial results for the fourth quarter and full year ended December 31, 2017.

Intersect ENT, Inc. reported financial results for the fourth quarter and year ended December 31, 2017.

ACADIA Pharmaceuticals Inc. announced its financial results for the fourth quarter and year ended December 31, 2017.

Masimo announced its financial results for the fourth quarter ended December 30, 2017.

Dthera Sciences (OTCQB:DTHR), a digital therapeutics company focused on developing innovative digital quality of life therapies for neurodegenerative diseases, is pleased to announce its CEO, Edward Cox, has been selected to co-chair the Digital Therapeutics and Digital Medicine Summit (DTxDM) alongside David Benshoof Klein, CEO of Click Therapeutics, a company developing software as prescription medical treatments.

Appointment of Raphaël Darteil as VP Non-Clinical Development & Product Profiling; EYP001 study 103 in chronic HBV patients set to deliver results in Q2 2018; Two Phase IIa studies with EYP001 in CHBV and in NASH to start in H2 2018

Growth is a result of client collaboration, dedication to quality outcomes and affordability

Xencor, Inc. reported financial results for the fourth quarter and full year ended December 31, 2017 and provided a review of 2017 and recent business and clinical highlights.